John M Maris, MD
Children's Hospital of Philadelphia, The University of Pennsylvania · Children's Hospital of Philadelphia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John M Maris, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:12 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02780128 · Next Generation Personalized Neuroblastoma TherapyYael P Mosse · terminated · Neuroblastoma, Cancer · principal investigator
- N/ANCT01169376 · Biomarkers in Young Patients With NeuroblastomaChildren's Oncology Group · completed · Neuroblastoma · principal investigator
- N/ANCT01163383 · 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access ProtocolJohn Maris · available · Neuroblastoma, Childhood Metastatic Pheochromocytoma · principal investigator
- Ph2NCT00293319 · 131 I-MIBG in Treating Patients With Refractory or Relapsed NeuroblastomaUniversity of California, San Francisco · completed · Neuroblastoma · unknown
- Ph2NCT00253435 · N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk NeuroblastomaNew Approaches to Neuroblastoma Therapy Consortium · completed · Neuroblastoma · principal investigator
- Ph1NCT00084422 · N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk NeuroblastomaNew Approaches to Neuroblastoma Therapy Consortium · completed · Neuroblastoma · principal investigator
- Ph1NCT00083135 · N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell TransplantationNew Approaches to Neuroblastoma Therapy Consortium · completed · Neuroblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NATURAL KILLER CELL BASED IMMUNOTHERAPYP01CA081403 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI ROBERT Charles SEEGER · fiscal years 2000 to 2014
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in neuroblastoma.